Chronic cognitive dysfunction after traumatic brain injury is improved with a phosphodiesterase 4B inhibitor

David J. Titus, Nicole M. Wilson, Julie E. Freund, Melissa M. Carballosa, Kevin E. Sikah, Concepcion Furones, W. Dalton Dietrich, Mark E. Gurney, Coleen M Atkins

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Learning and memory impairments are common in traumatic brain injury (TBI) survivors. However, there are no effective treatments to improve TBI-induced learning and memory impairments. TBI results in decreased cAMP signaling and reduced cAMP-response-element binding protein (CREB) activation, a critical pathway involved in learning and memory. TBI also acutely upregulates phosphodiesterase 4B2 (PDE4B2), which terminates cAMP signaling by hydrolyzing cAMP. Wehypothesized that a subtype-selective PDE4B inhibitor could reverse the learning deficits induced by TBI. To test this hypothesis, adult male Sprague-Dawley rats received sham surgery or moderate parasagittal fluid-percussion brain injury. At 3 months postsurgery, animals were administered a selective PDE4B inhibitor or vehicle before cue and contextual fear conditioning, water maze training and a spatial working memory task. Treatment with thePDE4Binhibitor significantly reversed the TBI-induced deficits in cue and contextual fear conditioning and water maze retention. To further understand the underlying mechanisms of these memory impairments, we examined hippocampal long-term potentiation (LTP). TBI resulted in a significant reduction in basal synaptic transmission and impaired expression of LTP. Treatment with the PDE4B inhibitor significantly reduced the deficits in basal synaptic transmission and rescued LTP expression. The PDE4B inhibitor reduced tumor necrosis factor-α levels and increased phosphorylated CREB levels after TBI, suggesting that this drug inhibited molecular pathways in the brain known to be regulated by PDE4B. These results suggest that a subtype-selective PDE4B inhibitor is a potential therapeutic to reverse chronic learning and memory dysfunction and deficits in hippocampal synaptic plasticity following TBI.

Original languageEnglish (US)
Pages (from-to)7095-7108
Number of pages14
JournalJournal of Neuroscience
Volume36
Issue number27
DOIs
StatePublished - Jul 6 2016

Fingerprint

Type 4 Cyclic Nucleotide Phosphodiesterase
Phosphodiesterase Inhibitors
Learning
Long-Term Potentiation
Cyclic AMP Response Element-Binding Protein
Synaptic Transmission
Fear
Cues
Percussion
Cognitive Dysfunction
Traumatic Brain Injury
Neuronal Plasticity
Critical Pathways
Water
Memory Disorders
Phosphoric Diester Hydrolases
Therapeutics
Short-Term Memory
Brain Injuries
Sprague Dawley Rats

Keywords

  • CAMP
  • Cognition
  • Learning
  • Long-term potentiation
  • Phosphodiesterase
  • Traumatic brain injury

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Chronic cognitive dysfunction after traumatic brain injury is improved with a phosphodiesterase 4B inhibitor. / Titus, David J.; Wilson, Nicole M.; Freund, Julie E.; Carballosa, Melissa M.; Sikah, Kevin E.; Furones, Concepcion; Dalton Dietrich, W.; Gurney, Mark E.; Atkins, Coleen M.

In: Journal of Neuroscience, Vol. 36, No. 27, 06.07.2016, p. 7095-7108.

Research output: Contribution to journalArticle

Titus, David J. ; Wilson, Nicole M. ; Freund, Julie E. ; Carballosa, Melissa M. ; Sikah, Kevin E. ; Furones, Concepcion ; Dalton Dietrich, W. ; Gurney, Mark E. ; Atkins, Coleen M. / Chronic cognitive dysfunction after traumatic brain injury is improved with a phosphodiesterase 4B inhibitor. In: Journal of Neuroscience. 2016 ; Vol. 36, No. 27. pp. 7095-7108.
@article{d433abf585a54f10b8db2a43ef6d5a16,
title = "Chronic cognitive dysfunction after traumatic brain injury is improved with a phosphodiesterase 4B inhibitor",
abstract = "Learning and memory impairments are common in traumatic brain injury (TBI) survivors. However, there are no effective treatments to improve TBI-induced learning and memory impairments. TBI results in decreased cAMP signaling and reduced cAMP-response-element binding protein (CREB) activation, a critical pathway involved in learning and memory. TBI also acutely upregulates phosphodiesterase 4B2 (PDE4B2), which terminates cAMP signaling by hydrolyzing cAMP. Wehypothesized that a subtype-selective PDE4B inhibitor could reverse the learning deficits induced by TBI. To test this hypothesis, adult male Sprague-Dawley rats received sham surgery or moderate parasagittal fluid-percussion brain injury. At 3 months postsurgery, animals were administered a selective PDE4B inhibitor or vehicle before cue and contextual fear conditioning, water maze training and a spatial working memory task. Treatment with thePDE4Binhibitor significantly reversed the TBI-induced deficits in cue and contextual fear conditioning and water maze retention. To further understand the underlying mechanisms of these memory impairments, we examined hippocampal long-term potentiation (LTP). TBI resulted in a significant reduction in basal synaptic transmission and impaired expression of LTP. Treatment with the PDE4B inhibitor significantly reduced the deficits in basal synaptic transmission and rescued LTP expression. The PDE4B inhibitor reduced tumor necrosis factor-α levels and increased phosphorylated CREB levels after TBI, suggesting that this drug inhibited molecular pathways in the brain known to be regulated by PDE4B. These results suggest that a subtype-selective PDE4B inhibitor is a potential therapeutic to reverse chronic learning and memory dysfunction and deficits in hippocampal synaptic plasticity following TBI.",
keywords = "CAMP, Cognition, Learning, Long-term potentiation, Phosphodiesterase, Traumatic brain injury",
author = "Titus, {David J.} and Wilson, {Nicole M.} and Freund, {Julie E.} and Carballosa, {Melissa M.} and Sikah, {Kevin E.} and Concepcion Furones and {Dalton Dietrich}, W. and Gurney, {Mark E.} and Atkins, {Coleen M}",
year = "2016",
month = "7",
day = "6",
doi = "10.1523/JNEUROSCI.3212-15.2016",
language = "English (US)",
volume = "36",
pages = "7095--7108",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "27",

}

TY - JOUR

T1 - Chronic cognitive dysfunction after traumatic brain injury is improved with a phosphodiesterase 4B inhibitor

AU - Titus, David J.

AU - Wilson, Nicole M.

AU - Freund, Julie E.

AU - Carballosa, Melissa M.

AU - Sikah, Kevin E.

AU - Furones, Concepcion

AU - Dalton Dietrich, W.

AU - Gurney, Mark E.

AU - Atkins, Coleen M

PY - 2016/7/6

Y1 - 2016/7/6

N2 - Learning and memory impairments are common in traumatic brain injury (TBI) survivors. However, there are no effective treatments to improve TBI-induced learning and memory impairments. TBI results in decreased cAMP signaling and reduced cAMP-response-element binding protein (CREB) activation, a critical pathway involved in learning and memory. TBI also acutely upregulates phosphodiesterase 4B2 (PDE4B2), which terminates cAMP signaling by hydrolyzing cAMP. Wehypothesized that a subtype-selective PDE4B inhibitor could reverse the learning deficits induced by TBI. To test this hypothesis, adult male Sprague-Dawley rats received sham surgery or moderate parasagittal fluid-percussion brain injury. At 3 months postsurgery, animals were administered a selective PDE4B inhibitor or vehicle before cue and contextual fear conditioning, water maze training and a spatial working memory task. Treatment with thePDE4Binhibitor significantly reversed the TBI-induced deficits in cue and contextual fear conditioning and water maze retention. To further understand the underlying mechanisms of these memory impairments, we examined hippocampal long-term potentiation (LTP). TBI resulted in a significant reduction in basal synaptic transmission and impaired expression of LTP. Treatment with the PDE4B inhibitor significantly reduced the deficits in basal synaptic transmission and rescued LTP expression. The PDE4B inhibitor reduced tumor necrosis factor-α levels and increased phosphorylated CREB levels after TBI, suggesting that this drug inhibited molecular pathways in the brain known to be regulated by PDE4B. These results suggest that a subtype-selective PDE4B inhibitor is a potential therapeutic to reverse chronic learning and memory dysfunction and deficits in hippocampal synaptic plasticity following TBI.

AB - Learning and memory impairments are common in traumatic brain injury (TBI) survivors. However, there are no effective treatments to improve TBI-induced learning and memory impairments. TBI results in decreased cAMP signaling and reduced cAMP-response-element binding protein (CREB) activation, a critical pathway involved in learning and memory. TBI also acutely upregulates phosphodiesterase 4B2 (PDE4B2), which terminates cAMP signaling by hydrolyzing cAMP. Wehypothesized that a subtype-selective PDE4B inhibitor could reverse the learning deficits induced by TBI. To test this hypothesis, adult male Sprague-Dawley rats received sham surgery or moderate parasagittal fluid-percussion brain injury. At 3 months postsurgery, animals were administered a selective PDE4B inhibitor or vehicle before cue and contextual fear conditioning, water maze training and a spatial working memory task. Treatment with thePDE4Binhibitor significantly reversed the TBI-induced deficits in cue and contextual fear conditioning and water maze retention. To further understand the underlying mechanisms of these memory impairments, we examined hippocampal long-term potentiation (LTP). TBI resulted in a significant reduction in basal synaptic transmission and impaired expression of LTP. Treatment with the PDE4B inhibitor significantly reduced the deficits in basal synaptic transmission and rescued LTP expression. The PDE4B inhibitor reduced tumor necrosis factor-α levels and increased phosphorylated CREB levels after TBI, suggesting that this drug inhibited molecular pathways in the brain known to be regulated by PDE4B. These results suggest that a subtype-selective PDE4B inhibitor is a potential therapeutic to reverse chronic learning and memory dysfunction and deficits in hippocampal synaptic plasticity following TBI.

KW - CAMP

KW - Cognition

KW - Learning

KW - Long-term potentiation

KW - Phosphodiesterase

KW - Traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=84977509446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977509446&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.3212-15.2016

DO - 10.1523/JNEUROSCI.3212-15.2016

M3 - Article

VL - 36

SP - 7095

EP - 7108

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 27

ER -